863 related articles for article (PubMed ID: 23470539)
21. Targeting cancer metabolism through synthetic lethality-based combinatorial treatment strategies.
Bajpai R; Shanmugam M
Curr Opin Oncol; 2018 Sep; 30(5):338-344. PubMed ID: 29994904
[TBL] [Abstract][Full Text] [Related]
22. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
Mazurek S
Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
[TBL] [Abstract][Full Text] [Related]
23. Action at a distance: allostery and the development of drugs to target cancer cell metabolism.
DeLaBarre B; Hurov J; Cianchetta G; Murray S; Dang L
Chem Biol; 2014 Sep; 21(9):1143-61. PubMed ID: 25237859
[TBL] [Abstract][Full Text] [Related]
24. Natural compounds regulate glycolysis in hypoxic tumor microenvironment.
Gao JL; Chen YG
Biomed Res Int; 2015; 2015():354143. PubMed ID: 25685782
[TBL] [Abstract][Full Text] [Related]
25. Development of dual inhibitors targeting pyruvate dehydrogenase kinases and human lactate dehydrogenase A: High-throughput virtual screening, synthesis and biological validation.
Xiang S; Huang D; He Q; Li J; Tam KY; Zhang SL; He Y
Eur J Med Chem; 2020 Oct; 203():112579. PubMed ID: 32688200
[TBL] [Abstract][Full Text] [Related]
26. Glycolytic, glutaminolytic and pentose-phosphate pathways in promyelocytic HL60 and DMSO-differentiated HL60 cells.
Ahmed N; Williams JF; Weidemann MJ
Biochem Mol Biol Int; 1993 Apr; 29(6):1055-67. PubMed ID: 8330014
[TBL] [Abstract][Full Text] [Related]
27. Demonstration of a heterogeneous distribution of glycolytic enzymes and of pyruvate kinase isoenzymes types M1 and M2 in unfertilized hen eggs.
Noda S; Schoner W
Biochim Biophys Acta; 1986 Dec; 884(3):395-401. PubMed ID: 2946322
[TBL] [Abstract][Full Text] [Related]
28. Effects of pentachlorophenol on enzymes involved in energy metabolism in the liver of the eel.
Boström SL; Johansson RG
Comp Biochem Physiol B; 1972 Feb; 41(2):359-69. PubMed ID: 4335365
[No Abstract] [Full Text] [Related]
29. The Warburg effect in 2012.
Bayley JP; Devilee P
Curr Opin Oncol; 2012 Jan; 24(1):62-7. PubMed ID: 22123234
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of LDH-A and glutaminase inhibition in vivo by hyperpolarized 13C-pyruvate magnetic resonance spectroscopy of tumors.
Dutta P; Le A; Vander Jagt DL; Tsukamoto T; Martinez GV; Dang CV; Gillies RJ
Cancer Res; 2013 Jul; 73(14):4190-5. PubMed ID: 23722553
[TBL] [Abstract][Full Text] [Related]
31. PKM2 Knockdown Induces Autophagic Cell Death via AKT/mTOR Pathway in Human Prostate Cancer Cells.
Dey P; Kundu A; Sachan R; Park JH; Ahn MY; Yoon K; Lee J; Kim ND; Kim IS; Lee BM; Kim HS
Cell Physiol Biochem; 2019; 52(6):1535-1552. PubMed ID: 31135122
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of glutaminase and glutamine synthetase in cancer.
Matés JM; Campos-Sandoval JA; Santos-Jiménez JL; Márquez J
Cancer Lett; 2019 Dec; 467():29-39. PubMed ID: 31574293
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Pyruvate Dehydrogenase Kinase as a Therapeutic Strategy against Cancer.
Sradhanjali S; Reddy MM
Curr Top Med Chem; 2018; 18(6):444-453. PubMed ID: 29788890
[TBL] [Abstract][Full Text] [Related]
34. Protein kinase CK2 modulation of pyruvate kinase M isoforms augments the Warburg effect in cancer cells.
Yang KM; Kim K
J Cell Biochem; 2018 Nov; 119(10):8501-8510. PubMed ID: 30015359
[TBL] [Abstract][Full Text] [Related]
35. Targeting cancer metabolism.
Teicher BA; Linehan WM; Helman LJ
Clin Cancer Res; 2012 Oct; 18(20):5537-45. PubMed ID: 23071355
[TBL] [Abstract][Full Text] [Related]
36. Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer.
Augoff K; Hryniewicz-Jankowska A; Tabola R
Cancer Lett; 2015 Mar; 358(1):1-7. PubMed ID: 25528630
[TBL] [Abstract][Full Text] [Related]
37. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
Zhang W; Hu X; Zhou W; Tam KY
J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
[TBL] [Abstract][Full Text] [Related]
38. Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma.
Shen YC; Ou DL; Hsu C; Lin KL; Chang CY; Lin CY; Liu SH; Cheng AL
Br J Cancer; 2013 Jan; 108(1):72-81. PubMed ID: 23257894
[TBL] [Abstract][Full Text] [Related]
39. Mitochondria, hexokinase and pyruvate kinase isozymes in the aerobic glycolysis of tumor cells.
Petrucci D; Cesare P; Colafarina S
Ital J Biochem; 1997 Sep; 46(3):131-41. PubMed ID: 9442422
[TBL] [Abstract][Full Text] [Related]
40. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy.
Anwar S; Shamsi A; Mohammad T; Islam A; Hassan MI
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188568. PubMed ID: 34023419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
